A set of 2 criteria for the needs of multi-criteria evaluation ‐ combinations D1–D10. by Roman Vavrek (13200141)

Subjects:

Fig 1 - by Farshid Maleki (20521649)

Subjects:

Fig 5 - by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

Fig 10 - by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Fig 4 - by Farshid Maleki (20521649)

Subjects:

Fig 9 - by Farshid Maleki (20521649)

Subjects:

Fig 6 - by Farshid Maleki (20521649)

Subjects:

Fig 7 - by Farshid Maleki (20521649)

Subjects:

Fig 8 - by Farshid Maleki (20521649)

Subjects:

Differential gene sets associated with the transcriptional host response to SARS-CoV-2 infection across serially collected samples. by Vasanthi Avadhanula (259546)

Subjects:

The volume of the right (red) and left (blue) IC are shown as a function of age on a logarithmic scale. by Pingling Kwok (14896191)

Subjects:

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)

Additional questions on vaccination. by Sara Saleh (6733619)

Subjects:

Socio-demographic characteristics of the population. by Sara Saleh (6733619)

Subjects:

Knowledge, attitude and practice scores in the general population and according to regions. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)

Subjects: